Changchun BCHT Biotechnology Co. (SHA:688276)

China flag China · Delayed Price · Currency is CNY
17.77
-0.53 (-2.90%)
Apr 9, 2026, 3:00 PM CST
Market Cap7.57B -21.2%
Revenue (ttm)591.81M -51.9%
Net Income-272.07M
EPS-0.66
Shares Out413.66M
PE Ration/a
Forward PEn/a
Dividend0.17 (0.95%)
Ex-Dividend DateJun 18, 2025
Volume1,632,794
Average Volume1,698,708
Open18.16
Previous Close18.30
Day's Range17.77 - 18.39
52-Week Range17.05 - 26.30
Beta0.12
RSI43.17
Earnings DateMar 12, 2026

About SHA:688276

Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. The company’s products include herpes zoster vaccine; varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and rabies vaccine (vero cell) for humans. Changchun BCHT Biotechnology Co. Ltd. was founded in 2004 and is based in Changchun, China. [Read more]

Sector Healthcare
Founded 2004
Employees 1,266
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688276
Full Company Profile

Financial Performance

Financial Statements